Gallbladder carcinoma: the role of p53 protein overexpression and Ki‐67 antigen expression as prognostic markers
Abstract
Gallbladder carcinoma is a relatively uncommon disease, accounting for about 0.3–0.7% of all cancer cases and having a peak incidence among women aged between 70 and 79 years [ 1 x 1 Albores‐Saavedra, J. and Henson, D.E. Tumors of the gallbladder and extrahepatic bile ducts. Atlas of Tumor Pathology, 2nd series. Fascicle 22. Armed Forces Institute of Pathology (AFIP), ; 1984 Google Scholar See all References 1 ]. The prognosis is poor, related to diagnostic delay and biological behaviour of the tumour [ 2 x 2 Diamantis, I., Karamitopoulou, E., Perentes, E., and Zimmermann, A. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology. 1995; 22: 774–779 Crossref | PubMed | Google Scholar See all References 2 ]. The pathogenic mechanisms of gallbladder carcinoma are only partially known, but genetic and environmental risk factors have been identified [ 1 x 1 Albores‐Saavedra, J. and Henson, D.E. Tumors of the gallbladder and extrahepatic bile ducts. Atlas of Tumor Pathology, 2nd series. Fascicle 22. Armed Forces Institute of Pathology (AFIP), ; 1984 Google Scholar See all References 1 , 3 x 3 Abi‐Rached, B. and Neugut, A. Diagnostic and management issues in gallbladder carcinoma. Oncology. 1995; 9: 19–30 PubMed | Google Scholar See all References 3 ].Keywords
This publication has 46 references indexed in Scilit:
- Overexpression of p53 protein in gallbladder carcinoma in North IndiaEuropean Journal of Surgical Oncology, 2000
- Correlation of p53 protein expression with gene mutation in gall‐bladder carcinomasPathology International, 1997
- APC, K‐ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall‐bladder suggest two genetic pathways in gall‐bladder carcinogenesisPathology International, 1996
- Expression of p53 in adenocarcinoma of the gallbladder and bile ductsLiver International, 1996
- p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of VaterPathology, 1995
- Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions.Journal of Clinical Pathology, 1994
- p53 and c‐erbB‐2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladderThe Journal of Pathology, 1993
- p53 Mutations in Human CancersScience, 1991
- A genetic model for colorectal tumorigenesisCell, 1990
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989